Company Filing History:
Years Active: 2003-2007
Title: Sachiko Okabe: Innovator in TNF-α Production Inhibition
Introduction
Sachiko Okabe is a prominent inventor based in Ageo, Japan. She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 2 patents, her work focuses on the inhibition of TNF-α production, which is crucial in managing inflammatory conditions.
Latest Patents
Okabe's latest patents include a TNF-α production inhibitor comprising kavalactone as an active ingredient. This invention provides a highly safe and effective means of inhibiting TNF-α production. It is useful as a drug or animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The invention also offers a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-α.
Career Highlights
Okabe is currently associated with Meiji Dairies Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on healthcare and treatment methodologies.
Collaborations
Some of her notable coworkers include Yoshinori Asakawa and Masashi Yamada, who have collaborated with her on various projects.
Conclusion
Sachiko Okabe's contributions to the field of medical research through her innovative patents highlight her role as a leading inventor in the fight against serious health conditions. Her work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.